Global Factor IX Concentrates Injection Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.
The global Factor IX Concentrates Injection market size is projected to grow from US$ 1029 million in 2024 to US$ 2081 million in 2030; it is expected to grow at a CAGR of 12.4% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Factor IX Concentrates Injection Industry Forecast” looks at past sales and reviews total world Factor IX Concentrates Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Factor IX Concentrates Injection sales for 2024 through 2030. With Factor IX Concentrates Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Factor IX Concentrates Injection industry.
This Insight Report provides a comprehensive analysis of the global Factor IX Concentrates Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Factor IX Concentrates Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Factor IX Concentrates Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Factor IX Concentrates Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Factor IX Concentrates Injection.
United States market for Factor IX Concentrates Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Factor IX Concentrates Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Factor IX Concentrates Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Factor IX Concentrates Injection players cover CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Factor IX Concentrates Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Factor IX Concentrates Injection market?
What factors are driving Factor IX Concentrates Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Factor IX Concentrates Injection market opportunities vary by end market size?
How does Factor IX Concentrates Injection break out by Type, by Application?
Factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.
The global Factor IX Concentrates Injection market size is projected to grow from US$ 1029 million in 2024 to US$ 2081 million in 2030; it is expected to grow at a CAGR of 12.4% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Factor IX Concentrates Injection Industry Forecast” looks at past sales and reviews total world Factor IX Concentrates Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Factor IX Concentrates Injection sales for 2024 through 2030. With Factor IX Concentrates Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Factor IX Concentrates Injection industry.
This Insight Report provides a comprehensive analysis of the global Factor IX Concentrates Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Factor IX Concentrates Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Factor IX Concentrates Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Factor IX Concentrates Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Factor IX Concentrates Injection.
United States market for Factor IX Concentrates Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Factor IX Concentrates Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Factor IX Concentrates Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Factor IX Concentrates Injection players cover CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Factor IX Concentrates Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Beriplex
- Profilnine
- Octaplex
- Prothromplex
- Cofact
- Other
- Hemophilia B
- Acquired Coagulation Factor Deficiency
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL Behring
- Grifols
- Octapharma
- Prothya Biosolutions
- Takeda
What is the 10-year outlook for the global Factor IX Concentrates Injection market?
What factors are driving Factor IX Concentrates Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Factor IX Concentrates Injection market opportunities vary by end market size?
How does Factor IX Concentrates Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Factor IX Concentrates Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Factor IX Concentrates Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Factor IX Concentrates Injection by Country/Region, 2019, 2023 & 2030
2.2 Factor IX Concentrates Injection Segment by Type
2.2.1 Beriplex
2.2.2 Profilnine
2.2.3 Octaplex
2.2.4 Prothromplex
2.2.5 Cofact
2.2.6 Other
2.3 Factor IX Concentrates Injection Sales by Type
2.3.1 Global Factor IX Concentrates Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Factor IX Concentrates Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Factor IX Concentrates Injection Sale Price by Type (2019-2024)
2.4 Factor IX Concentrates Injection Segment by Application
2.4.1 Hemophilia B
2.4.2 Acquired Coagulation Factor Deficiency
2.5 Factor IX Concentrates Injection Sales by Application
2.5.1 Global Factor IX Concentrates Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Factor IX Concentrates Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Factor IX Concentrates Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Factor IX Concentrates Injection Breakdown Data by Company
3.1.1 Global Factor IX Concentrates Injection Annual Sales by Company (2019-2024)
3.1.2 Global Factor IX Concentrates Injection Sales Market Share by Company (2019-2024)
3.2 Global Factor IX Concentrates Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Factor IX Concentrates Injection Revenue by Company (2019-2024)
3.2.2 Global Factor IX Concentrates Injection Revenue Market Share by Company (2019-2024)
3.3 Global Factor IX Concentrates Injection Sale Price by Company
3.4 Key Manufacturers Factor IX Concentrates Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Factor IX Concentrates Injection Product Location Distribution
3.4.2 Players Factor IX Concentrates Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FACTOR IX CONCENTRATES INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Factor IX Concentrates Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Factor IX Concentrates Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Factor IX Concentrates Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Factor IX Concentrates Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Factor IX Concentrates Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Factor IX Concentrates Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Factor IX Concentrates Injection Sales Growth
4.4 APAC Factor IX Concentrates Injection Sales Growth
4.5 Europe Factor IX Concentrates Injection Sales Growth
4.6 Middle East & Africa Factor IX Concentrates Injection Sales Growth
5 AMERICAS
5.1 Americas Factor IX Concentrates Injection Sales by Country
5.1.1 Americas Factor IX Concentrates Injection Sales by Country (2019-2024)
5.1.2 Americas Factor IX Concentrates Injection Revenue by Country (2019-2024)
5.2 Americas Factor IX Concentrates Injection Sales by Type (2019-2024)
5.3 Americas Factor IX Concentrates Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Factor IX Concentrates Injection Sales by Region
6.1.1 APAC Factor IX Concentrates Injection Sales by Region (2019-2024)
6.1.2 APAC Factor IX Concentrates Injection Revenue by Region (2019-2024)
6.2 APAC Factor IX Concentrates Injection Sales by Type (2019-2024)
6.3 APAC Factor IX Concentrates Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Factor IX Concentrates Injection by Country
7.1.1 Europe Factor IX Concentrates Injection Sales by Country (2019-2024)
7.1.2 Europe Factor IX Concentrates Injection Revenue by Country (2019-2024)
7.2 Europe Factor IX Concentrates Injection Sales by Type (2019-2024)
7.3 Europe Factor IX Concentrates Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Factor IX Concentrates Injection by Country
8.1.1 Middle East & Africa Factor IX Concentrates Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Factor IX Concentrates Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Factor IX Concentrates Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Factor IX Concentrates Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Factor IX Concentrates Injection
10.3 Manufacturing Process Analysis of Factor IX Concentrates Injection
10.4 Industry Chain Structure of Factor IX Concentrates Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Factor IX Concentrates Injection Distributors
11.3 Factor IX Concentrates Injection Customer
12 WORLD FORECAST REVIEW FOR FACTOR IX CONCENTRATES INJECTION BY GEOGRAPHIC REGION
12.1 Global Factor IX Concentrates Injection Market Size Forecast by Region
12.1.1 Global Factor IX Concentrates Injection Forecast by Region (2025-2030)
12.1.2 Global Factor IX Concentrates Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Factor IX Concentrates Injection Forecast by Type (2025-2030)
12.7 Global Factor IX Concentrates Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Factor IX Concentrates Injection Product Portfolios and Specifications
13.1.3 CSL Behring Factor IX Concentrates Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Factor IX Concentrates Injection Product Portfolios and Specifications
13.2.3 Grifols Factor IX Concentrates Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Octapharma
13.3.1 Octapharma Company Information
13.3.2 Octapharma Factor IX Concentrates Injection Product Portfolios and Specifications
13.3.3 Octapharma Factor IX Concentrates Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Octapharma Main Business Overview
13.3.5 Octapharma Latest Developments
13.4 Prothya Biosolutions
13.4.1 Prothya Biosolutions Company Information
13.4.2 Prothya Biosolutions Factor IX Concentrates Injection Product Portfolios and Specifications
13.4.3 Prothya Biosolutions Factor IX Concentrates Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Prothya Biosolutions Main Business Overview
13.4.5 Prothya Biosolutions Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Factor IX Concentrates Injection Product Portfolios and Specifications
13.5.3 Takeda Factor IX Concentrates Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Factor IX Concentrates Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Factor IX Concentrates Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Factor IX Concentrates Injection by Country/Region, 2019, 2023 & 2030
2.2 Factor IX Concentrates Injection Segment by Type
2.2.1 Beriplex
2.2.2 Profilnine
2.2.3 Octaplex
2.2.4 Prothromplex
2.2.5 Cofact
2.2.6 Other
2.3 Factor IX Concentrates Injection Sales by Type
2.3.1 Global Factor IX Concentrates Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Factor IX Concentrates Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Factor IX Concentrates Injection Sale Price by Type (2019-2024)
2.4 Factor IX Concentrates Injection Segment by Application
2.4.1 Hemophilia B
2.4.2 Acquired Coagulation Factor Deficiency
2.5 Factor IX Concentrates Injection Sales by Application
2.5.1 Global Factor IX Concentrates Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Factor IX Concentrates Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Factor IX Concentrates Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Factor IX Concentrates Injection Breakdown Data by Company
3.1.1 Global Factor IX Concentrates Injection Annual Sales by Company (2019-2024)
3.1.2 Global Factor IX Concentrates Injection Sales Market Share by Company (2019-2024)
3.2 Global Factor IX Concentrates Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Factor IX Concentrates Injection Revenue by Company (2019-2024)
3.2.2 Global Factor IX Concentrates Injection Revenue Market Share by Company (2019-2024)
3.3 Global Factor IX Concentrates Injection Sale Price by Company
3.4 Key Manufacturers Factor IX Concentrates Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Factor IX Concentrates Injection Product Location Distribution
3.4.2 Players Factor IX Concentrates Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FACTOR IX CONCENTRATES INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Factor IX Concentrates Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Factor IX Concentrates Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Factor IX Concentrates Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Factor IX Concentrates Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Factor IX Concentrates Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Factor IX Concentrates Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Factor IX Concentrates Injection Sales Growth
4.4 APAC Factor IX Concentrates Injection Sales Growth
4.5 Europe Factor IX Concentrates Injection Sales Growth
4.6 Middle East & Africa Factor IX Concentrates Injection Sales Growth
5 AMERICAS
5.1 Americas Factor IX Concentrates Injection Sales by Country
5.1.1 Americas Factor IX Concentrates Injection Sales by Country (2019-2024)
5.1.2 Americas Factor IX Concentrates Injection Revenue by Country (2019-2024)
5.2 Americas Factor IX Concentrates Injection Sales by Type (2019-2024)
5.3 Americas Factor IX Concentrates Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Factor IX Concentrates Injection Sales by Region
6.1.1 APAC Factor IX Concentrates Injection Sales by Region (2019-2024)
6.1.2 APAC Factor IX Concentrates Injection Revenue by Region (2019-2024)
6.2 APAC Factor IX Concentrates Injection Sales by Type (2019-2024)
6.3 APAC Factor IX Concentrates Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Factor IX Concentrates Injection by Country
7.1.1 Europe Factor IX Concentrates Injection Sales by Country (2019-2024)
7.1.2 Europe Factor IX Concentrates Injection Revenue by Country (2019-2024)
7.2 Europe Factor IX Concentrates Injection Sales by Type (2019-2024)
7.3 Europe Factor IX Concentrates Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Factor IX Concentrates Injection by Country
8.1.1 Middle East & Africa Factor IX Concentrates Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Factor IX Concentrates Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Factor IX Concentrates Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Factor IX Concentrates Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Factor IX Concentrates Injection
10.3 Manufacturing Process Analysis of Factor IX Concentrates Injection
10.4 Industry Chain Structure of Factor IX Concentrates Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Factor IX Concentrates Injection Distributors
11.3 Factor IX Concentrates Injection Customer
12 WORLD FORECAST REVIEW FOR FACTOR IX CONCENTRATES INJECTION BY GEOGRAPHIC REGION
12.1 Global Factor IX Concentrates Injection Market Size Forecast by Region
12.1.1 Global Factor IX Concentrates Injection Forecast by Region (2025-2030)
12.1.2 Global Factor IX Concentrates Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Factor IX Concentrates Injection Forecast by Type (2025-2030)
12.7 Global Factor IX Concentrates Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Factor IX Concentrates Injection Product Portfolios and Specifications
13.1.3 CSL Behring Factor IX Concentrates Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Factor IX Concentrates Injection Product Portfolios and Specifications
13.2.3 Grifols Factor IX Concentrates Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Octapharma
13.3.1 Octapharma Company Information
13.3.2 Octapharma Factor IX Concentrates Injection Product Portfolios and Specifications
13.3.3 Octapharma Factor IX Concentrates Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Octapharma Main Business Overview
13.3.5 Octapharma Latest Developments
13.4 Prothya Biosolutions
13.4.1 Prothya Biosolutions Company Information
13.4.2 Prothya Biosolutions Factor IX Concentrates Injection Product Portfolios and Specifications
13.4.3 Prothya Biosolutions Factor IX Concentrates Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Prothya Biosolutions Main Business Overview
13.4.5 Prothya Biosolutions Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Factor IX Concentrates Injection Product Portfolios and Specifications
13.5.3 Takeda Factor IX Concentrates Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Factor IX Concentrates Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Factor IX Concentrates Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Beriplex
Table 4. Major Players of Profilnine
Table 5. Major Players of Octaplex
Table 6. Major Players of Prothromplex
Table 7. Major Players of Cofact
Table 8. Major Players of Other
Table 9. Global Factor IX Concentrates Injection Sales by Type (2019-2024) & (K Units)
Table 10. Global Factor IX Concentrates Injection Sales Market Share by Type (2019-2024)
Table 11. Global Factor IX Concentrates Injection Revenue by Type (2019-2024) & ($ million)
Table 12. Global Factor IX Concentrates Injection Revenue Market Share by Type (2019-2024)
Table 13. Global Factor IX Concentrates Injection Sale Price by Type (2019-2024) & (US$/Unit)
Table 14. Global Factor IX Concentrates Injection Sale by Application (2019-2024) & (K Units)
Table 15. Global Factor IX Concentrates Injection Sale Market Share by Application (2019-2024)
Table 16. Global Factor IX Concentrates Injection Revenue by Application (2019-2024) & ($ million)
Table 17. Global Factor IX Concentrates Injection Revenue Market Share by Application (2019-2024)
Table 18. Global Factor IX Concentrates Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global Factor IX Concentrates Injection Sales by Company (2019-2024) & (K Units)
Table 20. Global Factor IX Concentrates Injection Sales Market Share by Company (2019-2024)
Table 21. Global Factor IX Concentrates Injection Revenue by Company (2019-2024) & ($ millions)
Table 22. Global Factor IX Concentrates Injection Revenue Market Share by Company (2019-2024)
Table 23. Global Factor IX Concentrates Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers Factor IX Concentrates Injection Producing Area Distribution and Sales Area
Table 25. Players Factor IX Concentrates Injection Products Offered
Table 26. Factor IX Concentrates Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Factor IX Concentrates Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Factor IX Concentrates Injection Sales Market Share Geographic Region (2019-2024)
Table 31. Global Factor IX Concentrates Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Factor IX Concentrates Injection Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Factor IX Concentrates Injection Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Factor IX Concentrates Injection Sales Market Share by Country/Region (2019-2024)
Table 35. Global Factor IX Concentrates Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Factor IX Concentrates Injection Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Factor IX Concentrates Injection Sales by Country (2019-2024) & (K Units)
Table 38. Americas Factor IX Concentrates Injection Sales Market Share by Country (2019-2024)
Table 39. Americas Factor IX Concentrates Injection Revenue by Country (2019-2024) & ($ millions)
Table 40. Americas Factor IX Concentrates Injection Sales by Type (2019-2024) & (K Units)
Table 41. Americas Factor IX Concentrates Injection Sales by Application (2019-2024) & (K Units)
Table 42. APAC Factor IX Concentrates Injection Sales by Region (2019-2024) & (K Units)
Table 43. APAC Factor IX Concentrates Injection Sales Market Share by Region (2019-2024)
Table 44. APAC Factor IX Concentrates Injection Revenue by Region (2019-2024) & ($ millions)
Table 45. APAC Factor IX Concentrates Injection Sales by Type (2019-2024) & (K Units)
Table 46. APAC Factor IX Concentrates Injection Sales by Application (2019-2024) & (K Units)
Table 47. Europe Factor IX Concentrates Injection Sales by Country (2019-2024) & (K Units)
Table 48. Europe Factor IX Concentrates Injection Revenue by Country (2019-2024) & ($ millions)
Table 49. Europe Factor IX Concentrates Injection Sales by Type (2019-2024) & (K Units)
Table 50. Europe Factor IX Concentrates Injection Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Factor IX Concentrates Injection Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Factor IX Concentrates Injection Revenue Market Share by Country (2019-2024)
Table 53. Middle East & Africa Factor IX Concentrates Injection Sales by Type (2019-2024) & (K Units)
Table 54. Middle East & Africa Factor IX Concentrates Injection Sales by Application (2019-2024) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Factor IX Concentrates Injection
Table 56. Key Market Challenges & Risks of Factor IX Concentrates Injection
Table 57. Key Industry Trends of Factor IX Concentrates Injection
Table 58. Factor IX Concentrates Injection Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Factor IX Concentrates Injection Distributors List
Table 61. Factor IX Concentrates Injection Customer List
Table 62. Global Factor IX Concentrates Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 63. Global Factor IX Concentrates Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Americas Factor IX Concentrates Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Americas Factor IX Concentrates Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. APAC Factor IX Concentrates Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 67. APAC Factor IX Concentrates Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Europe Factor IX Concentrates Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Europe Factor IX Concentrates Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Middle East & Africa Factor IX Concentrates Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Middle East & Africa Factor IX Concentrates Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Global Factor IX Concentrates Injection Sales Forecast by Type (2025-2030) & (K Units)
Table 73. Global Factor IX Concentrates Injection Revenue Forecast by Type (2025-2030) & ($ millions)
Table 74. Global Factor IX Concentrates Injection Sales Forecast by Application (2025-2030) & (K Units)
Table 75. Global Factor IX Concentrates Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 76. CSL Behring Basic Information, Factor IX Concentrates Injection Manufacturing Base, Sales Area and Its Competitors
Table 77. CSL Behring Factor IX Concentrates Injection Product Portfolios and Specifications
Table 78. CSL Behring Factor IX Concentrates Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 79. CSL Behring Main Business
Table 80. CSL Behring Latest Developments
Table 81. Grifols Basic Information, Factor IX Concentrates Injection Manufacturing Base, Sales Area and Its Competitors
Table 82. Grifols Factor IX Concentrates Injection Product Portfolios and Specifications
Table 83. Grifols Factor IX Concentrates Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Grifols Main Business
Table 85. Grifols Latest Developments
Table 86. Octapharma Basic Information, Factor IX Concentrates Injection Manufacturing Base, Sales Area and Its Competitors
Table 87. Octapharma Factor IX Concentrates Injection Product Portfolios and Specifications
Table 88. Octapharma Factor IX Concentrates Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Octapharma Main Business
Table 90. Octapharma Latest Developments
Table 91. Prothya Biosolutions Basic Information, Factor IX Concentrates Injection Manufacturing Base, Sales Area and Its Competitors
Table 92. Prothya Biosolutions Factor IX Concentrates Injection Product Portfolios and Specifications
Table 93. Prothya Biosolutions Factor IX Concentrates Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. Prothya Biosolutions Main Business
Table 95. Prothya Biosolutions Latest Developments
Table 96. Takeda Basic Information, Factor IX Concentrates Injection Manufacturing Base, Sales Area and Its Competitors
Table 97. Takeda Factor IX Concentrates Injection Product Portfolios and Specifications
Table 98. Takeda Factor IX Concentrates Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Takeda Main Business
Table 100. Takeda Latest Developments
Table 1. Factor IX Concentrates Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Factor IX Concentrates Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Beriplex
Table 4. Major Players of Profilnine
Table 5. Major Players of Octaplex
Table 6. Major Players of Prothromplex
Table 7. Major Players of Cofact
Table 8. Major Players of Other
Table 9. Global Factor IX Concentrates Injection Sales by Type (2019-2024) & (K Units)
Table 10. Global Factor IX Concentrates Injection Sales Market Share by Type (2019-2024)
Table 11. Global Factor IX Concentrates Injection Revenue by Type (2019-2024) & ($ million)
Table 12. Global Factor IX Concentrates Injection Revenue Market Share by Type (2019-2024)
Table 13. Global Factor IX Concentrates Injection Sale Price by Type (2019-2024) & (US$/Unit)
Table 14. Global Factor IX Concentrates Injection Sale by Application (2019-2024) & (K Units)
Table 15. Global Factor IX Concentrates Injection Sale Market Share by Application (2019-2024)
Table 16. Global Factor IX Concentrates Injection Revenue by Application (2019-2024) & ($ million)
Table 17. Global Factor IX Concentrates Injection Revenue Market Share by Application (2019-2024)
Table 18. Global Factor IX Concentrates Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global Factor IX Concentrates Injection Sales by Company (2019-2024) & (K Units)
Table 20. Global Factor IX Concentrates Injection Sales Market Share by Company (2019-2024)
Table 21. Global Factor IX Concentrates Injection Revenue by Company (2019-2024) & ($ millions)
Table 22. Global Factor IX Concentrates Injection Revenue Market Share by Company (2019-2024)
Table 23. Global Factor IX Concentrates Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers Factor IX Concentrates Injection Producing Area Distribution and Sales Area
Table 25. Players Factor IX Concentrates Injection Products Offered
Table 26. Factor IX Concentrates Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Factor IX Concentrates Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Factor IX Concentrates Injection Sales Market Share Geographic Region (2019-2024)
Table 31. Global Factor IX Concentrates Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Factor IX Concentrates Injection Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Factor IX Concentrates Injection Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Factor IX Concentrates Injection Sales Market Share by Country/Region (2019-2024)
Table 35. Global Factor IX Concentrates Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Factor IX Concentrates Injection Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Factor IX Concentrates Injection Sales by Country (2019-2024) & (K Units)
Table 38. Americas Factor IX Concentrates Injection Sales Market Share by Country (2019-2024)
Table 39. Americas Factor IX Concentrates Injection Revenue by Country (2019-2024) & ($ millions)
Table 40. Americas Factor IX Concentrates Injection Sales by Type (2019-2024) & (K Units)
Table 41. Americas Factor IX Concentrates Injection Sales by Application (2019-2024) & (K Units)
Table 42. APAC Factor IX Concentrates Injection Sales by Region (2019-2024) & (K Units)
Table 43. APAC Factor IX Concentrates Injection Sales Market Share by Region (2019-2024)
Table 44. APAC Factor IX Concentrates Injection Revenue by Region (2019-2024) & ($ millions)
Table 45. APAC Factor IX Concentrates Injection Sales by Type (2019-2024) & (K Units)
Table 46. APAC Factor IX Concentrates Injection Sales by Application (2019-2024) & (K Units)
Table 47. Europe Factor IX Concentrates Injection Sales by Country (2019-2024) & (K Units)
Table 48. Europe Factor IX Concentrates Injection Revenue by Country (2019-2024) & ($ millions)
Table 49. Europe Factor IX Concentrates Injection Sales by Type (2019-2024) & (K Units)
Table 50. Europe Factor IX Concentrates Injection Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Factor IX Concentrates Injection Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Factor IX Concentrates Injection Revenue Market Share by Country (2019-2024)
Table 53. Middle East & Africa Factor IX Concentrates Injection Sales by Type (2019-2024) & (K Units)
Table 54. Middle East & Africa Factor IX Concentrates Injection Sales by Application (2019-2024) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Factor IX Concentrates Injection
Table 56. Key Market Challenges & Risks of Factor IX Concentrates Injection
Table 57. Key Industry Trends of Factor IX Concentrates Injection
Table 58. Factor IX Concentrates Injection Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Factor IX Concentrates Injection Distributors List
Table 61. Factor IX Concentrates Injection Customer List
Table 62. Global Factor IX Concentrates Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 63. Global Factor IX Concentrates Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Americas Factor IX Concentrates Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Americas Factor IX Concentrates Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. APAC Factor IX Concentrates Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 67. APAC Factor IX Concentrates Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Europe Factor IX Concentrates Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Europe Factor IX Concentrates Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Middle East & Africa Factor IX Concentrates Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Middle East & Africa Factor IX Concentrates Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Global Factor IX Concentrates Injection Sales Forecast by Type (2025-2030) & (K Units)
Table 73. Global Factor IX Concentrates Injection Revenue Forecast by Type (2025-2030) & ($ millions)
Table 74. Global Factor IX Concentrates Injection Sales Forecast by Application (2025-2030) & (K Units)
Table 75. Global Factor IX Concentrates Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 76. CSL Behring Basic Information, Factor IX Concentrates Injection Manufacturing Base, Sales Area and Its Competitors
Table 77. CSL Behring Factor IX Concentrates Injection Product Portfolios and Specifications
Table 78. CSL Behring Factor IX Concentrates Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 79. CSL Behring Main Business
Table 80. CSL Behring Latest Developments
Table 81. Grifols Basic Information, Factor IX Concentrates Injection Manufacturing Base, Sales Area and Its Competitors
Table 82. Grifols Factor IX Concentrates Injection Product Portfolios and Specifications
Table 83. Grifols Factor IX Concentrates Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Grifols Main Business
Table 85. Grifols Latest Developments
Table 86. Octapharma Basic Information, Factor IX Concentrates Injection Manufacturing Base, Sales Area and Its Competitors
Table 87. Octapharma Factor IX Concentrates Injection Product Portfolios and Specifications
Table 88. Octapharma Factor IX Concentrates Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Octapharma Main Business
Table 90. Octapharma Latest Developments
Table 91. Prothya Biosolutions Basic Information, Factor IX Concentrates Injection Manufacturing Base, Sales Area and Its Competitors
Table 92. Prothya Biosolutions Factor IX Concentrates Injection Product Portfolios and Specifications
Table 93. Prothya Biosolutions Factor IX Concentrates Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. Prothya Biosolutions Main Business
Table 95. Prothya Biosolutions Latest Developments
Table 96. Takeda Basic Information, Factor IX Concentrates Injection Manufacturing Base, Sales Area and Its Competitors
Table 97. Takeda Factor IX Concentrates Injection Product Portfolios and Specifications
Table 98. Takeda Factor IX Concentrates Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Takeda Main Business
Table 100. Takeda Latest Developments
LIST OF FIGURES
Figure 1. Picture of Factor IX Concentrates Injection
Figure 2. Factor IX Concentrates Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Factor IX Concentrates Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Factor IX Concentrates Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Factor IX Concentrates Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Factor IX Concentrates Injection Sales Market Share by Country/Region (2023)
Figure 10. Factor IX Concentrates Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Beriplex
Figure 12. Product Picture of Profilnine
Figure 13. Product Picture of Octaplex
Figure 14. Product Picture of Prothromplex
Figure 15. Product Picture of Cofact
Figure 16. Product Picture of Other
Figure 17. Global Factor IX Concentrates Injection Sales Market Share by Type in 2023
Figure 18. Global Factor IX Concentrates Injection Revenue Market Share by Type (2019-2024)
Figure 19. Factor IX Concentrates Injection Consumed in Hemophilia B
Figure 20. Global Factor IX Concentrates Injection Market: Hemophilia B (2019-2024) & (K Units)
Figure 21. Factor IX Concentrates Injection Consumed in Acquired Coagulation Factor Deficiency
Figure 22. Global Factor IX Concentrates Injection Market: Acquired Coagulation Factor Deficiency (2019-2024) & (K Units)
Figure 23. Global Factor IX Concentrates Injection Sale Market Share by Application (2023)
Figure 24. Global Factor IX Concentrates Injection Revenue Market Share by Application in 2023
Figure 25. Factor IX Concentrates Injection Sales by Company in 2023 (K Units)
Figure 26. Global Factor IX Concentrates Injection Sales Market Share by Company in 2023
Figure 27. Factor IX Concentrates Injection Revenue by Company in 2023 ($ millions)
Figure 28. Global Factor IX Concentrates Injection Revenue Market Share by Company in 2023
Figure 29. Global Factor IX Concentrates Injection Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Factor IX Concentrates Injection Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Factor IX Concentrates Injection Sales 2019-2024 (K Units)
Figure 32. Americas Factor IX Concentrates Injection Revenue 2019-2024 ($ millions)
Figure 33. APAC Factor IX Concentrates Injection Sales 2019-2024 (K Units)
Figure 34. APAC Factor IX Concentrates Injection Revenue 2019-2024 ($ millions)
Figure 35. Europe Factor IX Concentrates Injection Sales 2019-2024 (K Units)
Figure 36. Europe Factor IX Concentrates Injection Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa Factor IX Concentrates Injection Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Factor IX Concentrates Injection Revenue 2019-2024 ($ millions)
Figure 39. Americas Factor IX Concentrates Injection Sales Market Share by Country in 2023
Figure 40. Americas Factor IX Concentrates Injection Revenue Market Share by Country (2019-2024)
Figure 41. Americas Factor IX Concentrates Injection Sales Market Share by Type (2019-2024)
Figure 42. Americas Factor IX Concentrates Injection Sales Market Share by Application (2019-2024)
Figure 43. United States Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC Factor IX Concentrates Injection Sales Market Share by Region in 2023
Figure 48. APAC Factor IX Concentrates Injection Revenue Market Share by Region (2019-2024)
Figure 49. APAC Factor IX Concentrates Injection Sales Market Share by Type (2019-2024)
Figure 50. APAC Factor IX Concentrates Injection Sales Market Share by Application (2019-2024)
Figure 51. China Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. India Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe Factor IX Concentrates Injection Sales Market Share by Country in 2023
Figure 59. Europe Factor IX Concentrates Injection Revenue Market Share by Country (2019-2024)
Figure 60. Europe Factor IX Concentrates Injection Sales Market Share by Type (2019-2024)
Figure 61. Europe Factor IX Concentrates Injection Sales Market Share by Application (2019-2024)
Figure 62. Germany Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 63. France Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 64. UK Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa Factor IX Concentrates Injection Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa Factor IX Concentrates Injection Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Factor IX Concentrates Injection Sales Market Share by Application (2019-2024)
Figure 70. Egypt Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Factor IX Concentrates Injection in 2023
Figure 76. Manufacturing Process Analysis of Factor IX Concentrates Injection
Figure 77. Industry Chain Structure of Factor IX Concentrates Injection
Figure 78. Channels of Distribution
Figure 79. Global Factor IX Concentrates Injection Sales Market Forecast by Region (2025-2030)
Figure 80. Global Factor IX Concentrates Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Factor IX Concentrates Injection Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Factor IX Concentrates Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Factor IX Concentrates Injection Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Factor IX Concentrates Injection Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Factor IX Concentrates Injection
Figure 2. Factor IX Concentrates Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Factor IX Concentrates Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Factor IX Concentrates Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Factor IX Concentrates Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Factor IX Concentrates Injection Sales Market Share by Country/Region (2023)
Figure 10. Factor IX Concentrates Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Beriplex
Figure 12. Product Picture of Profilnine
Figure 13. Product Picture of Octaplex
Figure 14. Product Picture of Prothromplex
Figure 15. Product Picture of Cofact
Figure 16. Product Picture of Other
Figure 17. Global Factor IX Concentrates Injection Sales Market Share by Type in 2023
Figure 18. Global Factor IX Concentrates Injection Revenue Market Share by Type (2019-2024)
Figure 19. Factor IX Concentrates Injection Consumed in Hemophilia B
Figure 20. Global Factor IX Concentrates Injection Market: Hemophilia B (2019-2024) & (K Units)
Figure 21. Factor IX Concentrates Injection Consumed in Acquired Coagulation Factor Deficiency
Figure 22. Global Factor IX Concentrates Injection Market: Acquired Coagulation Factor Deficiency (2019-2024) & (K Units)
Figure 23. Global Factor IX Concentrates Injection Sale Market Share by Application (2023)
Figure 24. Global Factor IX Concentrates Injection Revenue Market Share by Application in 2023
Figure 25. Factor IX Concentrates Injection Sales by Company in 2023 (K Units)
Figure 26. Global Factor IX Concentrates Injection Sales Market Share by Company in 2023
Figure 27. Factor IX Concentrates Injection Revenue by Company in 2023 ($ millions)
Figure 28. Global Factor IX Concentrates Injection Revenue Market Share by Company in 2023
Figure 29. Global Factor IX Concentrates Injection Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Factor IX Concentrates Injection Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Factor IX Concentrates Injection Sales 2019-2024 (K Units)
Figure 32. Americas Factor IX Concentrates Injection Revenue 2019-2024 ($ millions)
Figure 33. APAC Factor IX Concentrates Injection Sales 2019-2024 (K Units)
Figure 34. APAC Factor IX Concentrates Injection Revenue 2019-2024 ($ millions)
Figure 35. Europe Factor IX Concentrates Injection Sales 2019-2024 (K Units)
Figure 36. Europe Factor IX Concentrates Injection Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa Factor IX Concentrates Injection Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Factor IX Concentrates Injection Revenue 2019-2024 ($ millions)
Figure 39. Americas Factor IX Concentrates Injection Sales Market Share by Country in 2023
Figure 40. Americas Factor IX Concentrates Injection Revenue Market Share by Country (2019-2024)
Figure 41. Americas Factor IX Concentrates Injection Sales Market Share by Type (2019-2024)
Figure 42. Americas Factor IX Concentrates Injection Sales Market Share by Application (2019-2024)
Figure 43. United States Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC Factor IX Concentrates Injection Sales Market Share by Region in 2023
Figure 48. APAC Factor IX Concentrates Injection Revenue Market Share by Region (2019-2024)
Figure 49. APAC Factor IX Concentrates Injection Sales Market Share by Type (2019-2024)
Figure 50. APAC Factor IX Concentrates Injection Sales Market Share by Application (2019-2024)
Figure 51. China Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. India Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe Factor IX Concentrates Injection Sales Market Share by Country in 2023
Figure 59. Europe Factor IX Concentrates Injection Revenue Market Share by Country (2019-2024)
Figure 60. Europe Factor IX Concentrates Injection Sales Market Share by Type (2019-2024)
Figure 61. Europe Factor IX Concentrates Injection Sales Market Share by Application (2019-2024)
Figure 62. Germany Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 63. France Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 64. UK Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa Factor IX Concentrates Injection Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa Factor IX Concentrates Injection Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Factor IX Concentrates Injection Sales Market Share by Application (2019-2024)
Figure 70. Egypt Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries Factor IX Concentrates Injection Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Factor IX Concentrates Injection in 2023
Figure 76. Manufacturing Process Analysis of Factor IX Concentrates Injection
Figure 77. Industry Chain Structure of Factor IX Concentrates Injection
Figure 78. Channels of Distribution
Figure 79. Global Factor IX Concentrates Injection Sales Market Forecast by Region (2025-2030)
Figure 80. Global Factor IX Concentrates Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Factor IX Concentrates Injection Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Factor IX Concentrates Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Factor IX Concentrates Injection Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Factor IX Concentrates Injection Revenue Market Share Forecast by Application (2025-2030)
